Adimmune Corporation (TPE:4142)
Taiwan · Delayed Price · Currency is TWD 18.05
-0.20 (-1.10%)
Feb 11, 2026, 1:35 PM CST
Adimmune Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -508.6 | -242.75 | -639.89 | 290.98 | 43.07 | 1,241 |
Depreciation & Amortization | 201.22 | 204.98 | 213.17 | 248.06 | 213.97 | 213.62 |
Other Amortization | 10.12 | 10.72 | 10.96 | 11.26 | 11.94 | 13.97 |
Loss (Gain) From Sale of Assets | -0.02 | -0.23 | 0.04 | -0.01 | -0.01 | -0.16 |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -1.44 |
Stock-Based Compensation | 12.79 | 24.58 | 21.62 | 16.01 | 25.17 | 13.85 |
Provision & Write-off of Bad Debts | 10.33 | -0.15 | 393.88 | 4.92 | 0.07 | - |
Other Operating Activities | -94.54 | -75.23 | -128.34 | -133.41 | -83.51 | -42.72 |
Change in Accounts Receivable | 247.72 | 882.08 | -1,176 | -623.93 | -127.58 | 395.73 |
Change in Inventory | 61.91 | -101.59 | 132.92 | -153.45 | -203.83 | 125.85 |
Change in Accounts Payable | -8.04 | -11.16 | -6.46 | 43.2 | -17.58 | 13.35 |
Change in Unearned Revenue | -10.17 | -12.42 | 10.7 | -12.33 | -144.46 | 154.47 |
Change in Other Net Operating Assets | -96.79 | -10.35 | 274.95 | 16.75 | -197.76 | 193.96 |
Operating Cash Flow | -174.08 | 668.48 | -892.35 | -291.97 | -480.52 | 2,322 |
Capital Expenditures | -335.28 | -231.15 | -377.8 | -419.44 | -844.09 | -536.97 |
Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.16 |
Sale (Purchase) of Intangibles | -0.25 | -1.03 | -1.04 | -0.19 | -1.17 | -16.44 |
Investment in Securities | 1.84 | -100.96 | 87.54 | 121.88 | 114.07 | -298.46 |
Other Investing Activities | -3.01 | 22.22 | -75.27 | -24.33 | 2.34 | 1,234 |
Investing Cash Flow | -336.68 | -310.9 | -366.56 | -322.07 | -728.84 | 382.76 |
Short-Term Debt Issued | - | 60 | 520 | 20 | - | - |
Long-Term Debt Issued | - | 6.11 | 544.9 | 898 | - | 1,311 |
Total Debt Issued | 832.17 | 66.11 | 1,065 | 918 | - | 1,311 |
Short-Term Debt Repaid | - | -100 | - | - | - | - |
Long-Term Debt Repaid | - | -543.11 | -188.34 | -64.05 | -11.14 | -1,153 |
Total Debt Repaid | -207.88 | -643.11 | -188.34 | -64.05 | -11.14 | -1,153 |
Net Debt Issued (Repaid) | 624.29 | -577 | 876.56 | 853.95 | -11.14 | 157.51 |
Repurchase of Common Stock | - | - | - | -292.54 | - | - |
Common Dividends Paid | - | - | - | - | -214.75 | - |
Other Financing Activities | -154.82 | 98.2 | -17.26 | 261.78 | 3 | 166.37 |
Financing Cash Flow | 469.46 | -478.8 | 859.3 | 823.19 | -222.89 | 323.88 |
Foreign Exchange Rate Adjustments | 4.45 | 8.34 | 0.03 | -4.1 | -3.2 | 5.2 |
Net Cash Flow | -36.84 | -112.88 | -399.58 | 205.07 | -1,435 | 3,034 |
Free Cash Flow | -509.36 | 437.34 | -1,270 | -711.4 | -1,325 | 1,785 |
Free Cash Flow Margin | -42.41% | 28.09% | -71.15% | -31.60% | -73.84% | 95.48% |
Free Cash Flow Per Share | -1.21 | 1.04 | -3.01 | -1.66 | -3.08 | 4.35 |
Cash Interest Paid | 27.34 | 35.18 | 31.22 | 20.23 | 14.68 | 16.77 |
Levered Free Cash Flow | -317.61 | 634.84 | -1,078 | -638.73 | -1,187 | 664.56 |
Unlevered Free Cash Flow | -299.67 | 657.64 | -1,057 | -624.61 | -1,178 | 678.42 |
Change in Working Capital | 194.62 | 746.56 | -763.77 | -729.77 | -691.21 | 883.36 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.